Rheumatic Disease Clinics of North America

Article	Citations
Racial/Ethnic, Socioeconomic, and Geographic Disparities in the Epidemiology of Knee and Hip Osteoarthritis	57
Rheumatoid Arthritis	45
Treatment Guidelines in Rheumatoid Arthritis	41
Osteoarthritis Treatment Guidelines from Six Professional Societies	35
Racial/Ethnic and Socioeconomic Disparities in Osteoarthritis Management	33
Pathogenesis and Treatment of Refractory Disease Courses in Systemic Juvenile Idiopathic Arthritis	28
Understanding Lupus Disparities Through a Social Determinants of Health Framework	26
Basic Mechanisms of Pain in Osteoarthritis	26
Gender and Ethnic Inequities in Gout Burden and Management	24
B Cells in Systemic Lupus Erythematosus	22
Disparities in Lupus and Lupus Nephritis Care and Outcomes Among US Medicaid Beneficiaries	19
Systemic Lupus Erythematosus Classification and Diagnosis	19
Socioeconomic Status, Health Care, and Outcomes in Systemic Lupus Erythematosus	18
COVID-19 in Pediatrics	17
Low Back Pain in Adolescent and Geriatric Populations	16
Recent Updates in Juvenile Spondyloarthritis	15
Juvenile Localized Scleroderma	15
Racial Disparities in Systemic Sclerosis	15
Uveitis in Children and Adolescents	15
Targeting Nerve Growth Factor for Pain Management in Osteoarthritis—Clinical Efficacy and Safety	14
Racial Disparities in Rheumatology Through the Lens of Critical Race Theory	14
Health Disparities in Systemic Lupus Erythematosus	14
Neutrophil Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus	14
Use of Quality Measures to Identify Disparities in Health Care for Systemic Lupus Erythematosus	13
Treatment Update in Systemic Lupus Erythematous	12

Updates on Juvenile Dermatomyositis from the Last Decade: Classification to Outcomes	12
T Cells in Systemic Lupus Erythematosus	12
Environmental Triggers of Hyperuricemia and Gout	12
Juvenile Idiopathic Arthritis Treatment Updates	11
Disparities in Rheumatoid Arthritis Care and Health Service Solutions to Equity	11
Abnormal Mitochondrial Physiology in the Pathogenesis of Systemic Lupus Erythematosus	11
Behçet Syndrome	11
Management of Pregnancy in Lupus	10
Interferons in Systemic Lupus Erythematosus	10
The Power of Systems Biology	10
The Meaningful Role of Patients, and Other Stakeholders in Clinical Practice Guideline Development	10
Mental Health in Pediatric Rheumatology	9
Pain in Axial Spondyloarthritis	8
Pain Mechanisms in Patients with Rheumatic Diseases	8
Environmental Risk Factors for Osteoarthritis: The Impact on Individuals with Knee Joint Injury	8
Kawasaki Disease and Multisystem Inflammatory Syndrome in Children	8
How the American College of Rheumatology Develops Guidelines	8
Chronic Nonbacterial Osteomyelitis	8
The Categorization of Pain in Systemic Lupus Erythematosus	8
Treatment Guidelines in Gout	8
Management and Cure of Gouty Arthritis	8
The Temporomandibular Joint in Juvenile Idiopathic Arthritis	8
Understanding Risk Factors for Poor Outcomes in a Multiethnic Longitudinal Cohort	8
Giant Cell Arteritis and Polymyalgia Rheumatica	8
Understanding the Disproportionate Burden of Rheumatic Diseases in Indigenous North American Populations	8
The Contribution of Genetics and Epigenetics to Our Understanding of Health Disparities in Rheumatic Diseases	8
Recommendations for the Use of Nonsteroidal Anti-inflammatory Drugs and Cardiovascular Disease Risk	8
Unique Aspects of Pediatric Sjögren Disease	8
Recommendations for Systemic Lupus Erythematosus	8
Systemic Autoinflammatory Diseases	8
Health Disparities in Rheumatic Diseases	8
Why It Hurts	7
Disparities in Childhood-Onset Lupus	7
Disparities in Pediatric Rheumatic Diseases	7
Updates in Systemic Sclerosis Treatment and Applicability to Pediatric Scleroderma	7
Designing an Intervention to Improve Management of High-Risk Lupus Patients Through Care Coordination	7
Molecular Pathways in the Pathogenesis of Systemic Juvenile Idiopathic Arthritis	7
Ultrasonography in Pediatric Rheumatology	6
Leveraging Telemedicine as an Approach to Address Rheumatic Disease Health Disparities	6
Treatment of Inflammatory Arthritis in Systemic Sclerosis	6
Treatment Guidelines in Vasculitis	6
Environmental Risks for Spondyloarthropathies	6
Atherosclerotic Cardiovascular Risk Stratification in the Rheumatic Diseases:	6
Systemic Lupus Erythematosus Outcome Measures for Systemic Lupus Erythematosus Clinical Trials	5
Instrumental Substance Use Among Youth with Rheumatic Disease—A Biopsychosocial Model	5
Juvenile Fibromyalgia	5
Therapeutic Advances in Eosinophilic Granulomatosis with Polyangiitis	5
Gastrointestinal Tract Considerations Part I	5
Sexual Dimorphism in the Expression of Pain Phenotype in Preclinical Models of Rheumatoid Arthritis	5
Pediatric Rheumatic Disease in Lower to Middle-Income Countries	5

Patient Engagement in Pediatric Rheumatology Research	5
Systemic Lupus Erythematosus Risk	5
Lifestyle, Hormonal, and Metabolic Environmental Risks for Rheumatoid Arthritis	5
Pharmacosurveillance in Juvenile Idiopathic Arthritis	5
Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy	5
Nonpharmacologic Pain Management in Inflammatory Arthritis	5
Fibromyalgia	5
The Promises and Perils of Social Media for Pediatric Rheumatology	4
Implementation Science in Pediatric Rheumatology: A Path to Health Equity	4
The GRADE Method	4
Multisystem Inflammatory Syndrome in Children and Kawasaki Disease	4
Cardiovascular Health in Pediatric Rheumatologic Diseases	4
Venous Thromboembolism in the Inflammatory Rheumatic Diseases	4
Management of Knee Osteoarthritis	4
Biomarkers in Childhood-Onset Systemic Lupus Erythematosus	4
Antinuclear Antibody Testing for the Diagnosis of Systemic Lupus Erythematosus	3
Evidence for Biologic Drug Modifying Anti-Rheumatoid Drugs and Association with Cardiovascular Disease Risk Mitigation in Inflammatory Arthritis	3
NF-κB and Related Autoimmune and Autoinflammatory Diseases	3
Interstitial Lung Disease	3
CARRA	3
Vasculitis and Pregnancy	3
Rheumatic Complications of Immune Checkpoint Inhibitors	3
Gastrointestinal Tract Considerations: Part II	3
Treatment of Vascular Complications in Systemic Sclerosis	3
Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Obstetric Antiphospholipid Syndrome	3
Using the Electronic Health Record to Enhance Care in Pediatric Rheumatology	3
The Exciting Future for Scleroderma	3
Environmental Risks for Inflammatory Myopathies	3
Managing Cardiovascular Risk in Patients with Rheumatic Disease	3
Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica	3
Increasing Ancestral Diversity in Lupus Trials	3
Time Trends of Cardiovascular Disease in the General Population and Inflammatory Arthritis	3
Genetic Defects in Early-Onset Inflammatory Bowel Disease	2
Treatment Guidelines in Pediatric Rheumatic Diseases	2
Community-Engaged Research: Leveraging Community-Academic Partnerships to Reduce Disparities and Inequities in Lupus Care	2
Multi-Organ System Screening, Care, and Patient Support in Systemic Sclerosis	2
Inhalant and Additional Mucosal-Related Environmental Risks for Rheumatoid Arthritis	2
Ear, Nose, and Throat Manifestations of Vasculitis and Other Systemic Autoimmune Diseases	2
Environmental Triggers for Vasculitis	2
Environmental Risks for Systemic Sclerosis	2
Immune Checkpoint Inhibitor-induced Polymyalgia Rheumatica	2
Recent Advances in Pediatric Vasculitis	2
Patient-Reported Outcomes in Lupus	2
Transitioning to Adulthood with a Rheumatic Disease	2
The Role of Imaging in Diagnosis and Monitoring of Large Vessel Vasculitis	2
Patient Experience of Systemic Sclerosis–Related Calcinosis	2
Isolated Aortitis	2
Statin-Associated Myalgias and Muscle Injury—Recognizing and Managing Both While Still Lowering the Low-Density Lipoprotein	2
Precision Medicine	2
Central Nervous System Vasculitis	2
Lupus Cohorts	2
Cardiovascular Disease in Large Vessel Vasculitis	2
Innovative Trials and New Opportunities in SLE	2
The Emerging Telehealth Landscape in Pediatric Rheumatology	1
Expanding IPEX: Inborn Errors of Regulatory T Cells	1
Health Disparities in Rheumatic Diseases: Part I	1
Health Care Utilization	1
Systemic Lupus Erythematosus: The Next Generation of Ideas and Scientists	1
Targeting Environmental Risks to Prevent Rheumatic Disease	1
Treatment Approaches to Granulomatosis with Polyangiitis and Microscopic Polyangiitis	1
Understanding the Role and Challenges of Patient Preferences in Disparities in Rheumatologic Disease Care	1
Heart Failure in Rheumatic Disease	1
Scleroderma: Best Approaches to Patient Care	1
Managing Immunosuppression in Vasculitis Patients in Times of Coronavirus Disease 2019	1
Cannabinoids and Pain	1
Role of Lipoprotein Levels and Function in Atherosclerosis Associated with Autoimmune Rheumatic Diseases	1
Impact of Non-steroidal Anti-inflammatory Drugs, Glucocorticoids, and Disease-Modifying Anti-Rheumatic Drugs on Cancer Response to Immune Checkpoint Inhibitor Therapy	1
Role of Environment in Pediatric Rheumatic Diseases	1
Deficiency of Adenosine Deaminase 2	1
The Evaluation of Guideline Quality in Rheumatic Diseases	1
Health Disparities in Rheumatic Diseases: Part II	1
Mimickers of Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	1
Prospects of Disease-Modifying Osteoarthritis Drugs	1
Taxonomy of Quality of Care Indicators	1
Mechanisms and Emerging Therapies for Treatment of Seizures in Pediatric Autoimmune Encephalitis and Autoinflammatory/Autoimmune-Associated Epilepsy	1
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	1
Hal Holman of Stanford	1
The Impact of Pediatric Rheumatic Diseases on Sexual Health, Family Planning, and Pregnancy	1
Pulmonary Hypertension	1
Perioperative Management of Rheumatic Disease and Therapies	1

Lessons from Carl M. Pearson 1919 – 1981	1
Lupus	0
Patient Voices in Rheumatic Immune-related Adverse Events	0
Immune Checkpoint Inhibitor-induced Inflammatory Arthritis	0
Copyright	0
Eric Bywaters and Barbara Ansell	0
Copyright	0
Forthcoming Issues	0
Contents	0
John R. Ward, MD: Pioneer—Clinical Trials in Rheumatology	0
COPA Syndrome from Diagnosis to Treatment	0
Copyright	0
Imaging in Rheumatology	0
Approach to Diagnosing Inborn Errors of Immunity	0
Contributors	0
Central Nervous System Imaging in Rheumatic Diseases	0
Imaging of Rheumatic Diseases Affecting the Lower Limb	0
Copyright	0
Interventions to Improve COVID-19 Vaccine Hesitancy	0
Copyright	0
Highlights of Interdisciplinary Care in Rheumatology	0
Systemic Diseases and Heart Block	0
Contents	0
Copyright	0
Forthcoming Issues	0
Copyright	0
Contents	0
Rheumatology Pearls for the Primary Care Physician	0
Pediatric Rheumatology Comes of Age: Part I	0
Copyright	0
Contributors	0
Contributors	0
J. Claude Bennett, MD	0
Forthcoming Issues	0
Preface	0
Outcome Measures in Pediatric Rheumatic Disease	0
Gerald P Rodnan	0
Best Approaches to the Care of Systemic Sclerosis Patients	0
Pre-existing Autoimmune Diseases and Immune Checkpoint Inhibitors for Cancer Treatment: Considerations About Initiation, Flares, Immune-Related Adverse Events, and Cancer Progression	0
Copyright	0
Copyright	0
The Giants Of Rheumatology	0
Forthcoming Issues	0
Contributors	0
Imaging Challenges and Developments in Large-vessel Vasculitis	0
Approach to Systemic Sclerosis Patient Assessment	0
Contents	0
Vascular, Soft Tissue, and Musculoskeletal Imaging in Systemic Sclerosis	0
Contributors	0
Contributors	0
Rheumatic Immune-related Adverse Events	0
Pediatric Rheumatology Comes of Age: Part II	0
Health Disparities in Rheumatic Diseases - Issue 2	0
Environmental Triggers for Rheumatic Diseases	0
Forthcoming Issues	0
Pain in Rheumatic Diseases	0
Cardiovascular Comorbidities in Inflammatory Rheumatic Diseases	0
It Takes Oysters to Generate Pearls	0
Forthcoming Issues	0
Contents	0
Mental Health Considerations in Chronic Disease	0
Pediatric Rheumatology Comes of Age: Part I	0
H. Ralph Schumacher	0
Expanding the Treatment Team	0
Issue 1	0
Beyond Coronary Artery Disease	0
Contents	0
Foreword	0
Lessons from Cardiac and Vascular Biopsies from Patients with and without Inflammatory Rheumatic Diseases	0
Nathan Zvaifler	0
Contributors	0
Edmund Lawrence Dubois (1923–1985)	0
Copyright	0
Contents	0
Imaging in Inflammatory Bowel Disease	0
Contributors	0
Contributors	0
Contributors	0
Copyright	0
Copyright	0
Lessons Learned from the COVID-19 Pandemic in Rheumatology	0
Contents	0
Immune Checkpoint Inhibitor-induced Sicca Syndrome	0
The Role of Psychology in Pediatric Rheumatic Diseases	0
Contributors	0
Pain in Rheumatic Diseases	0
Environmental Triggers for Rheumatic Disease: From “Why Did I Get This?” to “How Can We Prevent This?”	0
Contents	0
Copyright	0
Forthcoming Issues	0
Foreword	0
Foreword	0
Primary Cardiac Involvement in Systemic Sclerosis	0
Rheumatic Disease Clinics of North America	0
Contributors	0